Fox Business - The Power to Prosper
Search Site

Pfizer

Lilly CEO sees margins hitting pre-patent cliff levels by ‘19

Eli Lilly CEO John Lechleiter discusses 2Q earnings and the impact of recent patent expirations.

Read More

  1. McGraw on the economy’s path to success

    International Chamber of Commerce chairman Harold ‘Terry’ McGraw III says the U.S. is not competitive to attract investment.

  2. The tax motivations of Medtronics’ Covidien deal

    U.S. Congressional candidate Claudia Tenney and Swiss America Trading Chairman Craig Smith on businesses’ efforts to reduce their tax burden.

  3. Could a tax repatriation holiday boost U.S. jobs?

    FBN’s Charles Payne, retail analyst Hitha Prabhakar, Penn Financial Group founder Matt McCall, FBN’s Tracy Byrnes and FOXBusiness.com reporter Kate Rogers on whether a tax holiday would benefit the economy.

  4. Europe regulators target Apple tax probe

    FOX Business contributor Bob Rice breaks down why Apple is facing questions by European regulators over taxes.

  5. Forbes: Hillary Clinton needs a positive agenda for U.S.

    Forbes Media chairman Steve Forbes on Hillary Clinton.

  6. How to play the M&A game

    Rich Peterson of S&P Capital IQ gives his outlook for deal flow.

  7. The key to stock-picking perfection

    M.D. Sass CEO Martin D. Sass gives insight into the markets.

  8. Stocks to watch: GOOGL, DOW

    Rosenthal Wealth Management Group President Larry Rosenthal, Platinum Partners President Uri Landesman and Tethys Partners Chief Market Strategist Bob Iaccino on the markets.

  9. Tax reform necessary for economic recovery?

    Nuveen Asset Management chief equity strategist Bob Doll and Federated Investors chief equity strategist Phil Orlando talk tax reform.

  10. German unemployment rises in May

    CMC Markets’ Michael Hewson with the latest on GE’s bid for Alstom and the German unemployment data.

  11. Eurozone economic sentiment rises in May

    IG chief market strategist Brenda Kelly with the latest on the European markets.

  12. Pfizer , AstraZeneca deal still alive?

    Argus Research president John Eade and JPMorgan Funds Chief Global Strategist David Kelly on whether AstraZeneca will re-engage with Pfizer .

  1. Johnson & Johnson CEO: We are staying in the U.S.

    Johnson & Johnson CEO Alex Gorsky discusses companies moving business out of the U.S. because of taxes and ObamaCare’s impact.

  2. Mega-deals to ramp up in August?

    Rich Jeanneret of E&Y Transaction Adivsor Americas, Jones Day Global M&A chairman Bob Profusek and Hedgeye Risk Management CEO Keith McCullough give their outlook for M&A deals.

  3. Global M&A deal adds up to $1.75T

    Mesirow Financial Vice Chairman Jeff Golman on major M&A deals and tips on investing.

  4. Conard: Unpatriotic tax policies are damaging our economy

    Former Bain Capital managing director Ed Conard and The Vanguard Group CEO Bill McNabb on businesses parking cash overseas.

  5. Stocks to watch: AMP, HAL

    USAA Investments V.P. John Toohey, Chase Investment Counsel President Peter Tuz, Bruinhill Partners President Michael Gurka and FBN’s Ashley Webster on the markets.

  6. How to bring cash back to America

    Schulte, Roth & Zabel managing partner Paul Roth weighs in on the U.S. corporate tax rate.

  7. When will an Alstom takeover deal be signed?

    Alpari’s James Hughes on the European markets.

‹ Prev12345Next ›
Freebase CC-BY
Source: Pfizer on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL